Sun Pharmaceutical Q2 PAT declines 36% YoY
Mumbai, Oct. 31 -- Revenue increased 5.87% sequentially from Rs 15,299.88 crore in Q1 FY27.
Adjusted net profit stood at Rs 2,792.38 crore, down 10.44% year on year from Rs 3,117.95 crore. Sequentially, adjusted net profit declined 8.14% from Rs 3,039.73 crore.
EBITDA increased 4.8% year on year to Rs 4,743.9 crore, while EBITDA margin stood at 29.3%. Research and development investment was Rs 778.4 crore, equivalent to 4.8% of sales.
Profit before tax stood at Rs 3,159.37 crore in Q2 FY27, down 22.92% vs previous quarter and 24.19% vs year-ago quarter.
Total expenditure increased 14.35% year on year to Rs 12,213.16 crore from Rs 10,680.76 crore. Raw material consumption rose 43% to Rs 2,318.70 crore, while employee expenses increased...
Click here to read full article from source
इस लेख के रीप्रिंट को खरीदने या इस प्रकाशन का पूरा फ़ीड प्राप्त करने के लिए, कृपया
हमे संपर्क करें.